New eczema drug for kids shows promise in itch relief
NCT ID NCT01840605
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 21 times
Summary
This study tested a new medicine called TAU-284 in 303 children aged 7 to 15 with atopic dermatitis (eczema). The goal was to see if it could reduce itching better than an existing drug, ketotifen fumarate. Children took the medicine and reported their itch levels over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medical Corporation Kojinkai Asanuma Dermatology Clinic
Hokkaido, Japan
Conditions
Explore the condition pages connected to this study.